Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olezarsen in Severe Hypertriglyceridemia
NCT05079919Phase 3Completed
- Sponsor
- Ionis Pharmaceuticals
- Start
- Oct 2021
- Primary completion
- Oct 2024
- Countries
- 23
01
Overview
A Phase 3 trial of olezarsen in hypertriglyceridemia, sponsored by Ionis Pharmaceuticals. Started Oct 2021; status: completed.
02
Drugs
olezarsen
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT05079919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05079919.